Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement

Clinical trial NCT00284050 · COMPLETED

Trial details

NCT number: NCT00284050
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2005-10-01
Primary completion: 2008-06-01
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.